Alzheon, Inc. (ALZH): Price and Financial Metrics


Alzheon, Inc. (ALZH): $0.00

0.00 (0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ALZH Stock Price Chart Interactive Chart >

Price chart for ALZH

ALZH Price/Volume Stats

Current price $0.00 52-week high $0.00
Prev. close $0.00 52-week low $0.00
Day low $0.00 Volume 0
Day high $0.00 Avg. volume 0
50-day MA $0.00 Dividend yield N/A
200-day MA $0.00 Market Cap N/A

Alzheon, Inc. (ALZH) Company Bio


Alzheon, Inc. operates as a clinical stage biopharmaceutical company in the United States and internationally. The company’s lead product is ALZ-801, an orally administered inhibitor of beta amyloid misfolding, which is in Phase III clinical trial for treating Alzheimer’s disease and other neurological disorders. Its lead preclinical candidate compound includes ALZ-1903, a chemical entity and potent inhibitor of beta amyloid misfolding. The company was founded in 2013 and is based in Framingham, Massachusetts.


ALZH Latest News Stream


Event/Time News Detail
Loading, please wait...

ALZH Latest Social Stream


Loading social stream, please wait...

View Full ALZH Social Stream

ALZH Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7395 seconds.